1-苯基-3,4-二氢异喹啉，CAS 登记号 52250-50-7，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 1-苯基-3,4-二氢异喹啉 的 CAS 号：52250-50-7，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
1-Phenyl-3,4-dihydroisoquinoline · CAS 52250-50-7 · C15H13N. UNII 96YVC3YJ6A.
| CAS Registry Number | 52250-50-7 |
|---|---|
| PubChem CID | 609926 |
| Molecular formula | C15H13N |
| IUPAC name | 1-phenyl-3,4-dihydroisoquinoline |
| UNII (FDA) | 96YVC3YJ6A |
| Molecular Weight | 207.27 |
|---|---|
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 1 |
| Exact Mass | 207.104799419 |
| Monoisotopic Mass | 207.104799419 |
| Topological Polar Surface Area | 12.4 |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Reported hazard statements | H302 (100%), H312 (100%), H315 (100%), H319 (100%), H332 (100%), H335 (100%) |
|---|
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
H312 (100%): Harmful in contact with skin [Warning Acute toxicity, dermal]
1-Phenyl-3,4-dihydroisoquinoline; 52250-50-7; Isoquinoline, 3,4-dihydro-1-phenyl-; 96YVC3YJ6A; DTXSID70346144; RefChem:76954; DTXCID60297217; 848-404-3; CTOQBSUYGFNMJX-UHFFFAOYSA-N; 1-Phenyl-3,4-dihydro-isoquinoline; MFCD01817309; Solifenacin Impurity B; AKOS 213-253; 3,4-Dihydro-1-phenylisoquinoline; 3,4-Dihydro-1-phenylisoquinoline; 1-Phenyl-3,4-dihydroisoquinoline;; A1BGD
CAS 52250-50-7; molecular formula C15H13N; molecular weight — g/mol.
1-Phenyl-3,4-dihydroisoquinoline, 52250-50-7, Isoquinoline, 3,4-dihydro-1-phenyl-, 96YVC3YJ6A, DTXSID70346144, RefChem:76954.
Hazard statements reported: H302, H312, H315, H319, H332.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.